Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Injecting anti-herpes antibodies locally can prevent skin lesions and sweating problems caused by herpes simplex virus in mice.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

Lower adiponectin and higher leptin levels may predict hair loss in alopecia areata.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Tacrolimus treatment for autoimmune hepatitis can cause hair loss.

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Higher NLR, PLR, and MPV may help diagnose androgenetic alopecia.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Special cells can help regrow hair in alopecia areata.

Some hair proteins are specific to hair, while others are also found in skin cells.

Baricitinib improved hair loss and arthritis in a lupus patient.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

New treatments for alopecia areata show promise in improving hair loss outcomes.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

Relapsing hepatitis A can cause prolonged abnormal liver tests even without symptoms.